,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-01-19 06:22:00,"After a rip-roaring performance in stocks last year, investors are right to wonder what could be in store in 2018.",0.35138368606567383,0.17537666857242584,0.47323963046073914,neutral,0.17600701749324799
1,2018-01-19 06:22:00,"Will markets continue their winning ways, or are investors due for a reckoning?",0.2288544923067093,0.032858360558748245,0.7382872104644775,neutral,0.19599613547325134
2,2018-01-19 06:22:00,"While anything can happen, I believe these three big trends offer investors a good shot at market-beating returns this year.",0.8775382041931152,0.015219609253108501,0.10724221169948578,positive,0.8623185753822327
3,2018-01-19 06:22:00,No.,0.16272185742855072,0.12095019966363907,0.716327965259552,neutral,0.04177165776491165
4,2018-01-19 06:22:00,"1: Own some oil

After peaking in 2014, oil prices collapsed.",0.0729966089129448,0.8319164514541626,0.0950869470834732,negative,-0.7589198350906372
5,2018-01-19 06:22:00,"Recently, they've been marching higher again, and I expect that trend will continue as global economic growth picks up this year.",0.8849136829376221,0.01510047260671854,0.09998584538698196,positive,0.8698132038116455
6,2018-01-19 06:22:00,"Emerging economies will enjoy the highest growth, but the economic outlook is solid for the biggest oil-consuming countries, too.",0.8230134844779968,0.01615137793123722,0.16083508729934692,positive,0.8068621158599854
7,2018-01-19 06:22:00,"The U.S., China, Japan, India, and Russia account for more than a third of worldwide oil demand, and each is expected to see GDP increases this year.",0.8890073895454407,0.019035296514630318,0.09195723384618759,positive,0.8699721097946167
8,2018-01-19 06:22:00,"The World Bank estimates that China's GDP will grow 6.4%, India's GDP will accelerate 7.3%, and Russia's GDP will increase 1.7% this year.",0.9283813834190369,0.0170008335262537,0.054617855697870255,positive,0.9113805294036865
9,2018-01-19 06:22:00,"Elsewhere, Japan's second-longest period of expansion since World War II is expected to continue with growth of about 1% in 2018.",0.9170826077461243,0.01414813008159399,0.068769171833992,positive,0.9029344916343689
10,2018-01-19 06:22:00,"Meanwhile, the Conference Board expects U.S. GDP will improve 2.9% this year compared to 2.3% in 2017.",0.9521273970603943,0.026057420298457146,0.021815143525600433,positive,0.926069974899292
11,2018-01-19 06:22:00,"Greater economic activity will benefit many sectors, but I think it will be particularly good news for shareholders of oil-centric stocks, many of which still trade far below their 2014 peaks despite the ground they've regained over the past few months.",0.9190616011619568,0.025519710034132004,0.05541858822107315,positive,0.8935418725013733
12,2018-01-19 06:22:00,"If you want diversified exposure to the oil patch, then the Energy Select Sector SPDR (NYSEMKT: XLE) may be a good bet.",0.15299008786678314,0.006271337624639273,0.8407385945320129,neutral,0.14671875536441803
13,2018-01-19 06:22:00,"Its top holdings include ExxonMobil (NYSE: XOM) , Chevron (NYSE: CVX) , and Schlumberger (NYSE: SLB) .",0.03131257742643356,0.005026604048907757,0.9636608362197876,neutral,0.026285972446203232
14,2018-01-19 06:22:00,"However, if you prefer investing in individual stocks, then I favor ExxonMobil for its global exposure and 3.5% dividend yield, or one of the beaten-up energy service companies such as Diamond Offshore (NYSE: DO) , an offshore driller that could finally see a pickup in demand if commodity prices cooperate.",0.40315940976142883,0.016030821949243546,0.5808097720146179,neutral,0.3871285915374756
15,2018-01-19 06:22:00,"Big pharmaceutical stocks aren't as sexy as their biotech cousins, but that might not be a bad thing for investors in 2018.",0.09428215771913528,0.2515789866447449,0.6541388034820557,neutral,-0.15729683637619019
16,2018-01-19 06:22:00,"While biotech stocks have seen shares soar on advances in precision and personalized medicine, big pharmaceutical stocks haven't rallied nearly as much -- and that could be creating an opportunity, especially for income-oriented investors.",0.9123196601867676,0.026685474440455437,0.06099482998251915,positive,0.885634183883667
17,2018-01-19 06:22:00,Many big pharmaceutical companies can be bought at a significant discount to the S&P 500's P/E ratio.,0.06684540212154388,0.06414709240198135,0.8690075278282166,neutral,0.0026983097195625305
18,2018-01-19 06:22:00,"For instance, you'll only pay about 13 times forward earnings to buy Pfizer (NYSE: PFE) , a pharmaceuticals giant that's paying investors a market-trouncing 3.5% dividend yield.",0.05747232586145401,0.07199177891016006,0.8705358505249023,neutral,-0.014519453048706055
19,2018-01-19 06:22:00,"Pfizer's been weighed down for years by declining revenue for its cholesterol-lowering drug, Lipitor.",0.020794333890080452,0.9679567217826843,0.011249013245105743,negative,-0.947162389755249
20,2018-01-19 06:22:00,"Lipitor was once the world's best-selling medicine, but it lost patent protection in 2011, and Lipitor's sales have been weighing on Pfizer's results ever since.",0.025657683610916138,0.9290139079093933,0.04532843083143234,negative,-0.9033561944961548
21,2018-01-19 06:22:00,"In 2018, Lipitor's sales have finally fallen to a point where further declines won't present nearly as stiff a headwind.",0.01771254651248455,0.9684202075004578,0.01386723667383194,negative,-0.9507076740264893
22,2018-01-19 06:22:00,"As a result, rising demand for Pfizer's expanding lineup of cancer drugs should provide the company with meaningful top-line growth this year, which it can then leverage against its past cost-cutting for higher profits.",0.951446533203125,0.01679728738963604,0.0317562110722065,positive,0.9346492290496826
23,2018-01-19 06:22:00,"While Pfizer is my favorite big-cap pharmaceutical stock to buy, investors seeking more diversification can consider adding the iShares U.S. Pharmaceutical ETF (NYSEMKT: IHE) to their portfolio.",0.3672600984573364,0.00828591175377369,0.6244539618492126,neutral,0.3589741885662079
24,2018-01-19 06:22:00,"It invests in 43 different pharmaceutical stocks of various sizes, but Johnson & Johnson (NYSE: JNJ) , Pfizer, and Merck & Co. (NYSE: MRK) are its three biggest positions; combined, they represent more than one-quarter of the fund's assets.",0.045156653970479965,0.005583751946687698,0.9492595791816711,neutral,0.03957290202379227
25,2018-01-19 06:22:00,"With U.S. unemployment hovering near 4%, companies will need to turn to technology if they want to increase their productivity.",0.8252047896385193,0.04745941236615181,0.1273358017206192,positive,0.7777453660964966
26,2018-01-19 06:22:00,There's simply not enough slack in employment for companies to rest on their heels.,0.03742585331201553,0.8075267672538757,0.15504740178585052,negative,-0.7701008915901184
27,2018-01-19 06:22:00,"Instead, they'll have to embrace solutions that eke out more productivity from their current employees.",0.8225381970405579,0.01770814321935177,0.15975376963615417,positive,0.8048300743103027
28,2018-01-19 06:22:00,And that brings me to my third trend to buy: software stocks.,0.14925961196422577,0.015365509316325188,0.8353748917579651,neutral,0.13389410078525543
29,2018-01-19 06:22:00,"As companies look for ways to produce more goods and services for less money, that should provide natural revenue tailwinds for big software companies that sell software productivity suites, such as Microsoft (NASDAQ: MSFT) , as well as niche productivity software companies such as Atlassian (NASDAQ: TEAM) , which markets HipChat, a team messaging solution, along with other team-oriented software.",0.27592191100120544,0.015282200649380684,0.7087959051132202,neutral,0.2606396973133087
30,2018-01-19 06:22:00,"Customer relationship management software companies like Salesforce (NYSE: CRM) , finance and human capital software companies like Workday (NASDAQ: WDAY) , and companies that market manufacturing software, such as SAP AG (NYSE: SAP) , could all see sales grow because of the need for companies to boost their productivity.",0.9318696856498718,0.016982588917016983,0.051147665828466415,positive,0.9148870706558228
31,2018-01-19 06:22:00,The cut in corporate tax rates adds conviction to this investment idea by providing companies more financial wiggle room to make these investments.,0.8870382308959961,0.016235822811722755,0.0967259630560875,positive,0.8708024024963379
32,2018-01-19 06:22:00,"You could buy any of these individual stocks to gain exposure to the productivity trend, or you could buy the iShares North American Technology Software ETF (NYSEMKT: IGV) , which has about a third of its money invested in Adobe (NASDAQ: ADBE) , Microsoft, and Salesforce.",0.1283675581216812,0.005112986546009779,0.8665195107460022,neutral,0.12325457483530045
33,2018-01-19 06:22:00,"Overall, while there's likely to be a lot of interesting and profit-friendly trends to profit from in 2018, I think oil, pharmaceuticals, and software are the most compelling trades to consider putting on now.",0.3216445744037628,0.009454503655433655,0.6689009666442871,neutral,0.31219005584716797
34,2018-01-19 06:22:00,"10 stocks we like better than Microsoft

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.144730806350708,0.02607131190598011,0.829197883605957,neutral,0.11865949630737305
35,2018-01-19 06:22:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has tripled the market.",0.46925464272499084,0.07301506400108337,0.4577302634716034,positive,0.39623957872390747
36,2018-01-19 06:22:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Microsoft wasn't one of them!",0.23639820516109467,0.013798929750919342,0.749802827835083,neutral,0.22259926795959473
37,2018-01-19 06:22:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
38,2018-01-19 06:22:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
39,2018-01-19 06:22:00,Teresa Kersten is an employee of LinkedIn and is a member of The Motley Fool's board of directors.,0.01943996734917164,0.016307445243000984,0.9642525911331177,neutral,0.0031325221061706543
40,2018-01-19 06:22:00,LinkedIn is owned by Microsoft.,0.012965702451765537,0.010095099918544292,0.9769392609596252,neutral,0.002870602533221245
41,2018-01-19 06:22:00,"Todd Campbell owns shares of Adobe Systems, iShares S&P GSTI Software Index, Microsoft, Pfizer, and Salesforce.com.",0.016935445368289948,0.011050413362681866,0.9720140695571899,neutral,0.005885032005608082
42,2018-01-19 06:22:00,His clients may have positions in the companies mentioned.,0.015623625367879868,0.014780024066567421,0.9695963263511658,neutral,0.0008436013013124466
43,2018-01-19 06:22:00,"The Motley Fool owns shares of and recommends Atlassian, Johnson & Johnson, and Workday.",0.02161051332950592,0.011386099271476269,0.967003345489502,neutral,0.010224414058029652
44,2018-01-19 06:22:00,The Motley Fool recommends Adobe Systems and Salesforce.com.,0.016770143061876297,0.032761719077825546,0.9504680633544922,neutral,-0.01599157601594925
45,2018-01-19 06:22:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
46,2018-01-19 06:22:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
